Allied Biotech Corporation (TPEX:1780)

Allied Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,348	1,666	1,580	1,340	1,454	1,603
Market Cap Growth	43.02%	5.41%	17.93%	-7.84%	-9.31%	-3.78%
Enterprise Value	2,301	1,603	1,584	1,422	1,463	1,516
Last Close Price	24.40	16.44	14.91	11.85	12.40	13.05
PE Ratio	24.89	16.51	16.22	9.13	111.49	20.18
PS Ratio	2.86	2.07	2.19	1.87	2.15	2.59
PB Ratio	1.98	1.39	1.35	1.13	1.35	1.40
P/TBV Ratio	1.98	1.39	1.35	1.13	1.35	1.40
P/FCF Ratio	17.06	8.46	17.62	12.23	64.80	603.66
P/OCF Ratio	13.92	7.44	11.48	8.16	20.08	26.96
EV/Sales Ratio	2.80	1.99	2.20	1.98	2.16	2.45
EV/EBITDA Ratio	12.42	11.11	10.40	8.61	8.58	9.59
EV/EBIT Ratio	18.54	18.19	17.86	14.25	13.10	14.78
EV/FCF Ratio	16.72	8.14	17.66	12.98	65.19	570.73
Debt / Equity Ratio	0.84	0.80	0.68	0.71	1.15	0.87
Debt / EBITDA Ratio	5.38	6.36	5.03	4.88	7.03	6.09
Debt / FCF Ratio	7.24	4.84	8.87	7.64	55.38	376.46
Asset Turnover	-	0.37	0.34	0.31	0.29	0.29
Inventory Turnover	-	0.97	0.79	0.81	0.84	0.82
Quick Ratio	1.12	1.12	1.01	1.02	0.93	1.11
Current Ratio	1.61	1.67	1.76	1.72	1.33	1.63
Return on Equity (ROE)	-	8.54%	8.28%	12.96%	1.17%	6.91%
Return on Assets (ROA)	-	2.54%	2.60%	2.70%	2.97%	3.05%
Return on Invested Capital (ROIC)	9.24%	5.70%	5.72%	6.57%	7.00%	7.06%
Return on Capital Employed (ROCE)	10.10%	7.00%	7.10%	7.70%	10.20%	8.00%
Earnings Yield	4.03%	6.06%	6.16%	10.95%	0.90%	4.96%
FCF Yield	5.86%	11.82%	5.68%	8.18%	1.54%	0.17%
Dividend Yield	4.10%	6.08%	5.70%	10.13%	4.03%	6.13%
Payout Ratio	101.51%	80.66%	117.50%	32.49%	583.66%	119.40%
Buyback Yield / Dilution	-0.31%	-0.37%	-0.20%	-0.43%	-0.05%	-0.22%
Total Shareholder Return	3.79%	5.71%	5.50%	9.69%	3.98%	5.91%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.